Actively Recruiting
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Led by Henan Cancer Hospital · Updated on 2025-04-23
200
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are conducting a prospective non-interventional observational study to explore the relationship between driver gene abnormalities and the clinical characteristics and prognosis of lymphoma in Chinese patients. The study aims to collect detailed data on genetic changes, demographic and pathological features, and treatment outcomes to understand how these factors correlate with disease progression and treatment response. Participants diagnosed with lymphoma according to WHO 2017 criteria are included in this study. There are no specific treatment interventions as this is an observational study. Data collection focuses on genetic abnormalities and clinical features without altering standard patient care. Participants will have their gene abnormalities and clinical features monitored over time, with outcomes such as the incidence of driver gene abnormalities assessed up to 36 months. Researchers will also evaluate the objective response rate and 5-year overall survival. The study involves collecting demographic and treatment data to analyze disease prognosis and treatment efficacy over a long-term follow-up period.
CONDITIONS
Brief Title
Correlation Between Driver Gene Abnormalities and Clinicopathological Characteristics and Disease Prognosis in Lymphoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed as lymphoma (according to WHO 2017 classification criteria)
- Life expectancy no less than 3 months
- Agreeing to sign the written informed consents
You will not qualify if you...
- Other malignant tumor history or active malignant tumor need be treated
- Researchers determine unsuited to participate in this trial
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 5 years
Participants with lymphoma are observed to collect data on driver gene abnormalities, clinicopathological characteristics, treatments, and disease prognosis.
Trial Site Locations
Total: 1 location
1
Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZhou university
Zhengzhou, Henan, China
Actively Recruiting
Research Team
Y
Yanyan Liu, M.D. Ph.D
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here